ZimVie
Yahoo Finance • last year
ZimVie Reports Third Quarter 2023 Financial Results and Provides Update to Annual Guidance
Third Party Net Sales of $202.9 million Net Loss of ($5.1) million; Net Loss Margin of (2.5%); Adjusted Net Income[1] of $2.2 millionDiluted EPS of ($0.19); Adjusted Diluted EPS[1] of $0.08Adjusted EBITDA[1] of $25.8 million; Adjusted EBIT... Full story
Yahoo Finance • last year
ZimVie Announces Over 2,000 Children Have Received The Tether™ VBT
WESTMINSTER, Colo., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that over 2,000 children worldwide have been treated with The Tether™ Verteb... Full story
Yahoo Finance • last year
ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions
WESTMINSTER, Colo., Oct. 17, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launch of Azure™ Multi-Platform Product Solutions, a comprehensiv... Full story
Yahoo Finance • last year
ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023
WESTMINSTER, Colo., Oct. 11, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the third quarter 2023 after market close on... Full story
Yahoo Finance • last year
ZimVie Announces the Recent Launch of Biotivity™ A/C Plus Membrane
WESTMINSTER, Colo., Oct. 10, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launch of the Biotivity™ A/C Plus Membrane, a growth factor rich... Full story
Yahoo Finance • last year
ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
WESTMINSTER, Colo., Sept. 26, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that on September 7, 2023, the U.S. Food and Drug Administration approved i... Full story
Yahoo Finance • last year
ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing
ZimVie and Brainlab will cooperate on achieving compatibility between ZimVie’s Vital™ and Virage® fixation systems with the Brainlab spine and trauma technologies for global co-marketing purposes WESTMINSTER, Colo., Aug. 17, 2023 (GLOBE... Full story
Yahoo Finance • last year
ZimVie to Report Second Quarter 2023 Financial Results on August 2, 2023
WESTMINSTER, Colo., July 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the second quarter 2023 after market close on... Full story
Yahoo Finance • 2 years ago
ZimVie Announces the Recent Launches of RegenerOss® CC Allograft Particulate and RegenerOss® Bone Graft Plug
WESTMINSTER, Colo., April 13, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launches of two additions to its biomaterials portfolio, the Reg... Full story
Yahoo Finance • 2 years ago
ZimVie to Report First Quarter 2023 Financial Results on May 3, 2023
WESTMINSTER, Colo., April 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the first quarter 2023 after market close on... Full story
Yahoo Finance • 2 years ago
ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®
WESTMINSTER, Colo., April 03, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that the French Republic has published its approval for the reimbursement o... Full story
Yahoo Finance • 2 years ago
ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results
FY 2022 Third Party Net Sales of $909.5 million FY 2022 Net Loss of ($63.9) million; Net Loss Margin of (7.0%); Adjusted Net Income[1] of $47.9 millionFY 2022 Diluted EPS of ($2.45); Adjusted Diluted EPS[1] of $1.84FY 2022 Adjusted EBITDA[... Full story
Yahoo Finance • 2 years ago
ZimVie Announces Launch of the RealGUIDE™ CAD and FULL SUITE Software Modules
WESTMINSTER, Colo., Feb. 23, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the RealGUIDE™ CAD and FULL SUITE modules, the latest innovati... Full story
Yahoo Finance • 2 years ago
ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced with Mobi-C®
WESTMINSTER, Colo., Jan. 30, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that over 200,000 Mobi-C Cervical Discs have been implanted worldwide. This... Full story
